📰 Multidisciplinary Sciences News
Page 9 - Multidisciplinary Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Multidisciplinary Sciences. Real-time updates on events, politics, business and more.
May 9, 2022
/PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative...
April 26, 2022
It is well known in physics and chemistry that equal charges repel each other, while opposite charges attract. It was long assumed that this principle also applies when enzymes – the biological ca ...
April 21, 2022
/PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative...
April 13, 2022
VANCOUVER, BC, April 13, 2022 /PRNewswire/ -- The global biobetters market size reached USD 27.37 Billion in 2021 and is expected to register a significantly rapid revenue CAGR during the forecast
April 5, 2022
/PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative...
March 31, 2022
/PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative...
March 29, 2022
BiondVax Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update - read this article along with other careers information, tips and advice on BioSpace
March 28, 2022
/PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative...
March 26, 2022
/PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative...
March 24, 2022
/PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative...